Niagen Bioscience Inc (NAGE) Research

Niagen Bioscience Inc operates as a biotechnology enterprise with a core focus on promoting healthy aging. This company is also renowned for its pioneering research into nicotinamide adenine dinucleotide.

Market snapshot

Symbol
NAGE
Price
$3.50
Day change
+3.86%
Market cap
$278.8M
P/E ratio
15.01x
52-week range
3.35-14.69
Sector
Healthcare
Industry
Biotechnology
Next earnings
in 2 months
Analyst price target
$10.50

Peer companies

  • Akebia Therapeutics, Inc. (AKBA)
  • Corvus Pharmaceuticals, Inc. (CRVS)
  • KalVista Pharmaceuticals, Inc. (KALV)
  • Keros Therapeutics, Inc. (KROS)
  • Olema Pharmaceuticals, Inc. (OLMA)
  • Prothena Corporation plc (PRTA)
  • REGENXBIO Inc. (RGNX)
  • Rigel Pharmaceuticals, Inc. (RIGL)

Recent insider activity

  • Fried Robert N — M-Exempt (20000 shares) on 2026-04-24
  • Fried Robert N — M-Exempt (20000 shares) on 2026-04-24
  • Lopez Carlos Luis — A-Award (41420 shares) on 2026-02-19
  • Pamir Ozan — A-Award (62131 shares) on 2026-02-19
  • Fried Robert N — A-Award (503937 shares) on 2026-02-19

Open Niagen Bioscience Inc (NAGE) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.